Compare TFX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFX | MIR |
|---|---|---|
| Founded | 1943 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | N/A | N/A |
| Metric | TFX | MIR |
|---|---|---|
| Price | $109.97 | $26.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $139.88 | $28.29 |
| AVG Volume (30 Days) | 732.0K | ★ 2.1M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $3,189,988,000.00 | $902,300,000.00 |
| Revenue This Year | $9.90 | $8.75 |
| Revenue Next Year | $10.51 | $23.17 |
| P/E Ratio | ★ N/A | $239.01 |
| Revenue Growth | 5.42 | ★ 7.82 |
| 52 Week Low | $102.58 | $12.00 |
| 52 Week High | $185.94 | $30.28 |
| Indicator | TFX | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 33.05 | 64.63 |
| Support Level | $108.39 | $23.89 |
| Resistance Level | $127.49 | $25.35 |
| Average True Range (ATR) | 3.05 | 0.78 |
| MACD | -1.50 | 0.28 |
| Stochastic Oscillator | 10.79 | 94.35 |
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.